These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. TWEAK, via its receptor Fn14, is a novel regulator of mesenchymal progenitor cells and skeletal muscle regeneration. Girgenrath M; Weng S; Kostek CA; Browning B; Wang M; Brown SA; Winkles JA; Michaelson JS; Allaire N; Schneider P; Scott ML; Hsu YM; Yagita H; Flavell RA; Miller JB; Burkly LC; Zheng TS EMBO J; 2006 Dec; 25(24):5826-39. PubMed ID: 17124496 [TBL] [Abstract][Full Text] [Related]
26. TWEAK, a member of the TNF superfamily, is a multifunctional cytokine that binds the TweakR/Fn14 receptor. Wiley SR; Winkles JA Cytokine Growth Factor Rev; 2003; 14(3-4):241-9. PubMed ID: 12787562 [TBL] [Abstract][Full Text] [Related]
27. TWEAK binding to the Fn14 cysteine-rich domain depends on charged residues located in both the A1 and D2 modules. Brown SA; Hanscom HN; Vu H; Brew SA; Winkles JA Biochem J; 2006 Jul; 397(2):297-304. PubMed ID: 16526941 [TBL] [Abstract][Full Text] [Related]
28. Therapeutic targeting of TWEAK/Fnl4 in cancer: exploiting the intrinsic tumor cell killing capacity of the pathway. Michaelson JS; Burkly LC Results Probl Cell Differ; 2009; 49():145-60. PubMed ID: 19513634 [TBL] [Abstract][Full Text] [Related]
29. The TWEAK-Fn14 cytokine-receptor axis: discovery, biology and therapeutic targeting. Winkles JA Nat Rev Drug Discov; 2008 May; 7(5):411-25. PubMed ID: 18404150 [TBL] [Abstract][Full Text] [Related]
30. Tumor necrosis factor-like weak inducer of apoptosis is a mitogen for liver progenitor cells. Tirnitz-Parker JE; Viebahn CS; Jakubowski A; Klopcic BR; Olynyk JK; Yeoh GC; Knight B Hepatology; 2010 Jul; 52(1):291-302. PubMed ID: 20578156 [TBL] [Abstract][Full Text] [Related]
31. Out of the TWEAKlight: Elucidating the Role of Fn14 and TWEAK in Acute Kidney Injury. Sanz AB; Ruiz-Andres O; Sanchez-Niño MD; Ruiz-Ortega M; Ramos AM; Ortiz A Semin Nephrol; 2016 May; 36(3):189-98. PubMed ID: 27339384 [TBL] [Abstract][Full Text] [Related]
35. Molecular characterization of cytokine TWEAK and its receptor Fn14 in pig (Sus scrofa). Shui Y; Guan ZB; Zhang SQ Vet Immunol Immunopathol; 2008 Dec; 126(3-4):396-402. PubMed ID: 18817982 [TBL] [Abstract][Full Text] [Related]
36. TWEAK/Fn14 Signaling Involvement in the Pathogenesis of Cutaneous Disease in the MRL/lpr Model of Spontaneous Lupus. Doerner JL; Wen J; Xia Y; Paz KB; Schairer D; Wu L; Chalmers SA; Izmirly P; Michaelson JS; Burkly LC; Friedman AJ; Putterman C J Invest Dermatol; 2015 Aug; 135(8):1986-1995. PubMed ID: 25826425 [TBL] [Abstract][Full Text] [Related]
37. TWEAK is a novel arthritogenic mediator. Perper SJ; Browning B; Burkly LC; Weng S; Gao C; Giza K; Su L; Tarilonte L; Crowell T; Rajman L; Runkel L; Scott M; Atkins GJ; Findlay DM; Zheng TS; Hess H J Immunol; 2006 Aug; 177(4):2610-20. PubMed ID: 16888023 [TBL] [Abstract][Full Text] [Related]
38. Lipopolysaccharide Upregulated Intestinal Epithelial Cell Expression of Fn14 and Activation of Fn14 Signaling Amplify Intestinal TLR4-Mediated Inflammation. Qi X; Qin L; Du R; Chen Y; Lei M; Deng M; Wang J Front Cell Infect Microbiol; 2017; 7():315. PubMed ID: 28744451 [TBL] [Abstract][Full Text] [Related]
39. TWEAK in inclusion-body myositis muscle: possible pathogenic role of a cytokine inhibiting myogenesis. Morosetti R; Gliubizzi C; Sancricca C; Broccolini A; Gidaro T; Lucchini M; Mirabella M Am J Pathol; 2012 Apr; 180(4):1603-13. PubMed ID: 22314077 [TBL] [Abstract][Full Text] [Related]
40. A soluble Fn14-Fc decoy receptor reduces infarct volume in a murine model of cerebral ischemia. Yepes M; Brown SA; Moore EG; Smith EP; Lawrence DA; Winkles JA Am J Pathol; 2005 Feb; 166(2):511-20. PubMed ID: 15681834 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]